Non-Drug-Eluting Devices Industry Research Report 2025

Summary

According to APO Research, the global Non-Drug-Eluting Devices market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Non-Drug-Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Non-Drug-Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Non-Drug-Eluting Devices is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Non-Drug-Eluting Devices include Teleflex Incorporated, Johnson & Johnson, Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Stryker Corporation, Smith & Nephew plc., Peter Surgical and Integra Lifesciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Drug-Eluting Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Drug-Eluting Devices.

The report will help the Non-Drug-Eluting Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Non-Drug-Eluting Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Drug-Eluting Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Non-Drug-Eluting Devices Segment by Company

Teleflex Incorporated
Johnson & Johnson
Medtronic
Boston Scientific Corporation
B. Braun Melsungen AG
Stryker Corporation
Smith & Nephew plc.
Peter Surgical
Integra Lifesciences
DemeTECH Corporation
ConMed Corporation
Non-Drug-Eluting Devices Segment by Type

Implants
Sutures
Non-Drug-Eluting Devices Segment by Application

Hospital
Ambulatory Surgical Centers
Non-Drug-Eluting Devices Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers


High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Drug-Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-Drug-Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Drug-Eluting Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Non-Drug-Eluting Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Non-Drug-Eluting Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Non-Drug-Eluting Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Non-Drug-Eluting Devices Market Size (2020-2031)
2.2.2 Global Non-Drug-Eluting Devices Sales (2020-2031)
2.2.3 Global Non-Drug-Eluting Devices Market Average Price (2020-2031)
2.3 Non-Drug-Eluting Devices by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Implants
2.3.3 Sutures
2.4 Non-Drug-Eluting Devices by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital
2.4.3 Ambulatory Surgical Centers
3 Market Competitive Landscape by Manufacturers
3.1 Global Non-Drug-Eluting Devices Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Non-Drug-Eluting Devices Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Non-Drug-Eluting Devices Revenue of Manufacturers (2020-2025)
3.4 Global Non-Drug-Eluting Devices Average Price by Manufacturers (2020-2025)
3.5 Global Non-Drug-Eluting Devices Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Non-Drug-Eluting Devices, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Non-Drug-Eluting Devices, Product Type & Application
3.8 Global Manufacturers of Non-Drug-Eluting Devices, Established Date
3.9 Global Non-Drug-Eluting Devices Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Teleflex Incorporated
4.1.1 Teleflex Incorporated Company Information
4.1.2 Teleflex Incorporated Business Overview
4.1.3 Teleflex Incorporated Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Teleflex Incorporated Non-Drug-Eluting Devices Product Portfolio
4.1.5 Teleflex Incorporated Recent Developments
4.2 Johnson & Johnson
4.2.1 Johnson & Johnson Company Information
4.2.2 Johnson & Johnson Business Overview
4.2.3 Johnson & Johnson Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Johnson & Johnson Non-Drug-Eluting Devices Product Portfolio
4.2.5 Johnson & Johnson Recent Developments
4.3 Medtronic
4.3.1 Medtronic Company Information
4.3.2 Medtronic Business Overview
4.3.3 Medtronic Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Medtronic Non-Drug-Eluting Devices Product Portfolio
4.3.5 Medtronic Recent Developments
4.4 Boston Scientific Corporation
4.4.1 Boston Scientific Corporation Company Information
4.4.2 Boston Scientific Corporation Business Overview
4.4.3 Boston Scientific Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Boston Scientific Corporation Non-Drug-Eluting Devices Product Portfolio
4.4.5 Boston Scientific Corporation Recent Developments
4.5 B. Braun Melsungen AG
4.5.1 B. Braun Melsungen AG Company Information
4.5.2 B. Braun Melsungen AG Business Overview
4.5.3 B. Braun Melsungen AG Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.5.4 B. Braun Melsungen AG Non-Drug-Eluting Devices Product Portfolio
4.5.5 B. Braun Melsungen AG Recent Developments
4.6 Stryker Corporation
4.6.1 Stryker Corporation Company Information
4.6.2 Stryker Corporation Business Overview
4.6.3 Stryker Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Stryker Corporation Non-Drug-Eluting Devices Product Portfolio
4.6.5 Stryker Corporation Recent Developments
4.7 Smith & Nephew plc.
4.7.1 Smith & Nephew plc. Company Information
4.7.2 Smith & Nephew plc. Business Overview
4.7.3 Smith & Nephew plc. Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Smith & Nephew plc. Non-Drug-Eluting Devices Product Portfolio
4.7.5 Smith & Nephew plc. Recent Developments
4.8 Peter Surgical
4.8.1 Peter Surgical Company Information
4.8.2 Peter Surgical Business Overview
4.8.3 Peter Surgical Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Peter Surgical Non-Drug-Eluting Devices Product Portfolio
4.8.5 Peter Surgical Recent Developments
4.9 Integra Lifesciences
4.9.1 Integra Lifesciences Company Information
4.9.2 Integra Lifesciences Business Overview
4.9.3 Integra Lifesciences Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Integra Lifesciences Non-Drug-Eluting Devices Product Portfolio
4.9.5 Integra Lifesciences Recent Developments
4.10 DemeTECH Corporation
4.10.1 DemeTECH Corporation Company Information
4.10.2 DemeTECH Corporation Business Overview
4.10.3 DemeTECH Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.10.4 DemeTECH Corporation Non-Drug-Eluting Devices Product Portfolio
4.10.5 DemeTECH Corporation Recent Developments
4.11 ConMed Corporation
4.11.1 ConMed Corporation Company Information
4.11.2 ConMed Corporation Business Overview
4.11.3 ConMed Corporation Non-Drug-Eluting Devices Sales, Revenue and Gross Margin (2020-2025)
4.11.4 ConMed Corporation Non-Drug-Eluting Devices Product Portfolio
4.11.5 ConMed Corporation Recent Developments
5 Global Non-Drug-Eluting Devices Market Scenario by Region
5.1 Global Non-Drug-Eluting Devices Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Non-Drug-Eluting Devices Sales by Region: 2020-2031
5.2.1 Global Non-Drug-Eluting Devices Sales by Region: 2020-2025
5.2.2 Global Non-Drug-Eluting Devices Sales by Region: 2026-2031
5.3 Global Non-Drug-Eluting Devices Revenue by Region: 2020-2031
5.3.1 Global Non-Drug-Eluting Devices Revenue by Region: 2020-2025
5.3.2 Global Non-Drug-Eluting Devices Revenue by Region: 2026-2031
5.4 North America Non-Drug-Eluting Devices Market Facts & Figures by Country
5.4.1 North America Non-Drug-Eluting Devices Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Non-Drug-Eluting Devices Sales by Country (2020-2031)
5.4.3 North America Non-Drug-Eluting Devices Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Non-Drug-Eluting Devices Market Facts & Figures by Country
5.5.1 Europe Non-Drug-Eluting Devices Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Non-Drug-Eluting Devices Sales by Country (2020-2031)
5.5.3 Europe Non-Drug-Eluting Devices Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Non-Drug-Eluting Devices Market Facts & Figures by Country
5.6.1 Asia Pacific Non-Drug-Eluting Devices Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Non-Drug-Eluting Devices Sales by Country (2020-2031)
5.6.3 Asia Pacific Non-Drug-Eluting Devices Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Non-Drug-Eluting Devices Market Facts & Figures by Country
5.7.1 South America Non-Drug-Eluting Devices Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Non-Drug-Eluting Devices Sales by Country (2020-2031)
5.7.3 South America Non-Drug-Eluting Devices Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Non-Drug-Eluting Devices Market Facts & Figures by Country
5.8.1 Middle East and Africa Non-Drug-Eluting Devices Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Non-Drug-Eluting Devices Sales by Country (2020-2031)
5.8.3 Middle East and Africa Non-Drug-Eluting Devices Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Non-Drug-Eluting Devices Sales by Type (2020-2031)
6.1.1 Global Non-Drug-Eluting Devices Sales by Type (2020-2031) & (K Units)
6.1.2 Global Non-Drug-Eluting Devices Sales Market Share by Type (2020-2031)
6.2 Global Non-Drug-Eluting Devices Revenue by Type (2020-2031)
6.2.1 Global Non-Drug-Eluting Devices Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Non-Drug-Eluting Devices Revenue Market Share by Type (2020-2031)
6.3 Global Non-Drug-Eluting Devices Price by Type (2020-2031)
7 Segment by Application
7.1 Global Non-Drug-Eluting Devices Sales by Application (2020-2031)
7.1.1 Global Non-Drug-Eluting Devices Sales by Application (2020-2031) & (K Units)
7.1.2 Global Non-Drug-Eluting Devices Sales Market Share by Application (2020-2031)
7.2 Global Non-Drug-Eluting Devices Revenue by Application (2020-2031)
7.2.1 Global Non-Drug-Eluting Devices Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Non-Drug-Eluting Devices Revenue Market Share by Application (2020-2031)
7.3 Global Non-Drug-Eluting Devices Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Non-Drug-Eluting Devices Value Chain Analysis
8.1.1 Non-Drug-Eluting Devices Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Non-Drug-Eluting Devices Production Mode & Process
8.2 Non-Drug-Eluting Devices Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Non-Drug-Eluting Devices Distributors
8.2.3 Non-Drug-Eluting Devices Customers
9 Global Non-Drug-Eluting Devices Analyzing Market Dynamics
9.1 Non-Drug-Eluting Devices Industry Trends
9.2 Non-Drug-Eluting Devices Industry Drivers
9.3 Non-Drug-Eluting Devices Industry Opportunities and Challenges
9.4 Non-Drug-Eluting Devices Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings